Abdulsalam Mohammed Aleid, Saud Nayef Aldanyowi, Ayat Aleid, Khaled Albazli, Ghadeer Mohammad Fatani, Sami Almalki
{"title":"现代神经刺激方式的荟萃分析-神经刺激技术的进展。","authors":"Abdulsalam Mohammed Aleid, Saud Nayef Aldanyowi, Ayat Aleid, Khaled Albazli, Ghadeer Mohammad Fatani, Sami Almalki","doi":"10.25259/SNI_656_2024","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Chronic pain is a debilitating condition that affects about 3% of the population globally. Conventionally, pharmacologic approaches, psychotherapy, and surgery have been used in the management of chronic refractory pain. However, over the past decades, advances in neurotechnology have enabled modern novel techniques of neurostimulation, such as spinal cord stimulation (SCS) and dorsal root ganglion (DRG), to be used in the management of chronic neuropathic pain that does not respond to conventional management. This review, therefore, aims to establish the efficacy of these two novel technologies in the management of chronic neuropathic pain compared to conventional medical management (CMM) techniques.</p><p><strong>Methods: </strong>A systematic search was conducted on three electronic databases, PubMed, Science Direct, and CENTRAL, for all relevant articles to the study topic. After a detailed review by two independent reviewers, only the articles that met the inclusion criteria were included. The Review Manager 5.4 software was utilized to conduct a meta-analysis of the outcomes of pain reduction.</p><p><strong>Results: </strong>Our online search yielded 345 articles; however, only eight studies were included in the analysis according to our inclusion criteria. The results from our pooled analysis indicated that SCS and dorsal root stimulation both resulted in a significant reduction in the rating of chronic pain mean difference (MD) (-4.73; 95% confidence interval [CI] [-4.76, -4.71] <i>P</i> < 0.00001) and MD (-1.09; 95% CI [-1.29, -0.90] <i>P</i> < 0.00001), respectively. Similarly, for the studies that reported percentage change in pain rating, the pooled analysis showed that SCS resulted in a higher percentage reduction in pain rating compared to CMM MD (69.47; 95% CI [64.31, 74.64] <i>P</i> < 0.00001).</p><p><strong>Conclusion: </strong>Based on the results of our analysis, we conclude that advances in neurostimulation techniques, such as SCS and DRG stimulation, have resulted in better management of chronic neuropathic pain compared to conventional pain management techniques.</p>","PeriodicalId":94217,"journal":{"name":"Surgical neurology international","volume":"16 ","pages":"146"},"PeriodicalIF":0.0000,"publicationDate":"2025-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12065515/pdf/","citationCount":"0","resultStr":"{\"title\":\"A meta-analysis of modern neuro-stimulation modalities-Advances in neuro-stimulation techniques.\",\"authors\":\"Abdulsalam Mohammed Aleid, Saud Nayef Aldanyowi, Ayat Aleid, Khaled Albazli, Ghadeer Mohammad Fatani, Sami Almalki\",\"doi\":\"10.25259/SNI_656_2024\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Chronic pain is a debilitating condition that affects about 3% of the population globally. Conventionally, pharmacologic approaches, psychotherapy, and surgery have been used in the management of chronic refractory pain. However, over the past decades, advances in neurotechnology have enabled modern novel techniques of neurostimulation, such as spinal cord stimulation (SCS) and dorsal root ganglion (DRG), to be used in the management of chronic neuropathic pain that does not respond to conventional management. This review, therefore, aims to establish the efficacy of these two novel technologies in the management of chronic neuropathic pain compared to conventional medical management (CMM) techniques.</p><p><strong>Methods: </strong>A systematic search was conducted on three electronic databases, PubMed, Science Direct, and CENTRAL, for all relevant articles to the study topic. After a detailed review by two independent reviewers, only the articles that met the inclusion criteria were included. The Review Manager 5.4 software was utilized to conduct a meta-analysis of the outcomes of pain reduction.</p><p><strong>Results: </strong>Our online search yielded 345 articles; however, only eight studies were included in the analysis according to our inclusion criteria. The results from our pooled analysis indicated that SCS and dorsal root stimulation both resulted in a significant reduction in the rating of chronic pain mean difference (MD) (-4.73; 95% confidence interval [CI] [-4.76, -4.71] <i>P</i> < 0.00001) and MD (-1.09; 95% CI [-1.29, -0.90] <i>P</i> < 0.00001), respectively. Similarly, for the studies that reported percentage change in pain rating, the pooled analysis showed that SCS resulted in a higher percentage reduction in pain rating compared to CMM MD (69.47; 95% CI [64.31, 74.64] <i>P</i> < 0.00001).</p><p><strong>Conclusion: </strong>Based on the results of our analysis, we conclude that advances in neurostimulation techniques, such as SCS and DRG stimulation, have resulted in better management of chronic neuropathic pain compared to conventional pain management techniques.</p>\",\"PeriodicalId\":94217,\"journal\":{\"name\":\"Surgical neurology international\",\"volume\":\"16 \",\"pages\":\"146\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-04-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12065515/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Surgical neurology international\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.25259/SNI_656_2024\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Surgical neurology international","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.25259/SNI_656_2024","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
背景:慢性疼痛是一种使人衰弱的疾病,影响着全球约3%的人口。传统上,药物治疗、心理治疗和手术治疗已被用于治疗慢性难治性疼痛。然而,在过去的几十年里,神经技术的进步使得神经刺激的现代新技术,如脊髓刺激(SCS)和背根神经节(DRG),被用于治疗传统治疗无效的慢性神经性疼痛。因此,本综述旨在确定这两种新技术在治疗慢性神经性疼痛方面的疗效,并与传统医学管理(CMM)技术进行比较。方法:在PubMed、Science Direct和CENTRAL三个电子数据库中进行系统检索,获取与研究主题相关的所有文章。经过两位独立审稿人的详细审查,只有符合纳入标准的文章被纳入。使用Review Manager 5.4软件对疼痛减轻的结果进行meta分析。结果:我们的在线搜索得到345篇文章;然而,根据我们的纳入标准,只有8项研究被纳入分析。我们的汇总分析结果表明,SCS和背根刺激均可显著降低慢性疼痛平均差(MD)评级(-4.73;95%置信区间[CI] [-4.76, -4.71] P < 0.00001)和MD (-1.09;95% CI [-1.29, -0.90] P < 0.00001)。同样,对于报告疼痛评分百分比变化的研究,汇总分析显示,与CMM MD相比,SCS导致疼痛评分降低的百分比更高(69.47;95% ci [64.31, 74.64] p < 0.00001)。结论:基于我们的分析结果,我们得出结论,与传统的疼痛管理技术相比,神经刺激技术的进步,如SCS和DRG刺激,已经导致更好的慢性神经性疼痛管理。
A meta-analysis of modern neuro-stimulation modalities-Advances in neuro-stimulation techniques.
Background: Chronic pain is a debilitating condition that affects about 3% of the population globally. Conventionally, pharmacologic approaches, psychotherapy, and surgery have been used in the management of chronic refractory pain. However, over the past decades, advances in neurotechnology have enabled modern novel techniques of neurostimulation, such as spinal cord stimulation (SCS) and dorsal root ganglion (DRG), to be used in the management of chronic neuropathic pain that does not respond to conventional management. This review, therefore, aims to establish the efficacy of these two novel technologies in the management of chronic neuropathic pain compared to conventional medical management (CMM) techniques.
Methods: A systematic search was conducted on three electronic databases, PubMed, Science Direct, and CENTRAL, for all relevant articles to the study topic. After a detailed review by two independent reviewers, only the articles that met the inclusion criteria were included. The Review Manager 5.4 software was utilized to conduct a meta-analysis of the outcomes of pain reduction.
Results: Our online search yielded 345 articles; however, only eight studies were included in the analysis according to our inclusion criteria. The results from our pooled analysis indicated that SCS and dorsal root stimulation both resulted in a significant reduction in the rating of chronic pain mean difference (MD) (-4.73; 95% confidence interval [CI] [-4.76, -4.71] P < 0.00001) and MD (-1.09; 95% CI [-1.29, -0.90] P < 0.00001), respectively. Similarly, for the studies that reported percentage change in pain rating, the pooled analysis showed that SCS resulted in a higher percentage reduction in pain rating compared to CMM MD (69.47; 95% CI [64.31, 74.64] P < 0.00001).
Conclusion: Based on the results of our analysis, we conclude that advances in neurostimulation techniques, such as SCS and DRG stimulation, have resulted in better management of chronic neuropathic pain compared to conventional pain management techniques.